Acupuncture for Patients With Chronic Tension-type Headache
1 other identifier
interventional
218
1 country
1
Brief Summary
Two hundred and eighteen patients with chronic tension-type headache(CTTH) will be randomly assigned to an experimental group (acupuncture) and a control group (superficial acupuncture) in a 1:1 ratio. Participants in both groups will receive 20 sessions of acupuncture over 8 weeks, and the same acupoints will be selected in acupuncture treatments.The study cycle will last 36 weeks, including a 4-week baseline period, a 8-week treatment period and a 24-week follow-up period. And the primary outcome will be measured at the end of 16th week. While, the secondary outcomes will be measured at the baseline, the 4th, 8th,12th,16th,20th,24th,28th and 32nd week after randomization.After each treatment, participants will finish the Massachusetts General Hospital (MGH) Acupuncture Sensation Scale (MASS) to evaluate deqi sensations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2016
CompletedFirst Submitted
Initial submission to the registry
March 22, 2017
CompletedFirst Posted
Study publicly available on registry
April 28, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 10, 2019
CompletedSeptember 19, 2019
September 1, 2019
3 years
March 22, 2017
September 18, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Responder rate
The responder rate is defined as \>50% reduction in the number of headache days per four week
16 weeks after randomization
Secondary Outcomes (7)
The number of days with headache
at baseline before randomization, 4, 8, 12, 16, 20, 24, 28 and 32 weeks after randomization
The mean pain intensity of tension-type headache during 4 weeks
at baseline before randomization, 4, 8, 12, 16, 20, 24, 28 and 32 weeks after randomization
The rate of medication intake during 4 weeks
at baseline before randomization, 4, 8, 12, 16, 20, 24, 28 and 32 weeks after randomization
Evaluation of quality of life
at baseline before randomization, 4, 8, 12, 16, 20, 24, 28 and 32 weeks after randomization
Evaluation of anxiety state
at baseline before randomization, 4, 8, 12, 16, 20, 24, 28 and 32 weeks after randomization
- +2 more secondary outcomes
Study Arms (2)
Acupuncture
EXPERIMENTALThe needles will be inserted into the acupoints and the depths will be adjusted to the standard permissible layers, then even reinforcing-reducing technique will be performed on the needles until achieving deqi sensation.The needles will be retained for 30 minutes in each session and manipulated twice every 10 minutes with intermittent stimulation. Each manipulation will last for 20 seconds.
Superficial acupuncture
OTHERThe selected acupoints will be punctured superficially by the depth of 1-3 mm, and the needles will be retained for 30 minutes without any manipulation.
Interventions
The needles will be inserted into the acupoints and the depths will be adjusted to the standard permissible layers, then even reinforcing-reducing technique will be performed on the needles until achieving deqi sensation.The needles will be retained for 30 minutes in each session and manipulated twice every 10 minutes with intermittent stimulation. Each manipulation will last for 30 seconds.
The selected acupoints will be punctured superficially by the depth of 1-3 mm, and the needles will be retained for 30 minutes without any manipulation.
Eligibility Criteria
You may qualify if:
- Meeting the diagnostic criteria of CTTH in the international classification of headache disorders, 3rd edition (beta version) (ICHD-III beta);
- Aged 18-65 years;
- Having the ability of understanding and completing the headache dairy;
- Volunteering to this study and able to provide written informed consent.
You may not qualify if:
- Not suffering tension-type headache during the pervious 3 months;
- Taking any prophylactic headache medication during the previous one month;
- Headache due to organic disorders (e.g. subarachnoid hemorrhage, cerebral hemorrhage, cerebral embolism, cerebral thrombosis, vascular malformation, arthritis, hypertension, arteriosclerosis);
- Having serious diseases of the heart, liver, kidney or other organs;
- In pregnancy or lactation, or planning to be pregnant in 6 months;
- In unconsciousness, or having psychosis;
- Having bleeding disorders or getting infectious;
- Unwilling to take parts in this study or with low compliance;
- Addicted to smoking, alcohol or drugs;
- Taking parts in other clinical studies at the same time.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chengdu University of Traditional Chinese Medicine
Chengdu, Sichuan, 610075, China
Related Publications (2)
Zheng H, Gao T, Zheng QH, Lu LY, Hou TH, Zhang SS, Zhou SY, Hao XY, Wang L, Zhao L, Liang FR, Li Y. Acupuncture for Patients With Chronic Tension-Type Headache: A Randomized Controlled Trial. Neurology. 2022 Oct 3;99(14):e1560-e1569. doi: 10.1212/WNL.0000000000200670.
PMID: 35732505DERIVEDLu L, Zheng H, Zheng Q, Hao X, Zhou S, Zhang S, Wei T, Gao T, Duan D, Zhao L, Li N, Li Y. The long-term effect of acupuncture for patients with chronic tension-type headache: study protocol for a randomized controlled trial. Trials. 2017 Oct 3;18(1):453. doi: 10.1186/s13063-017-2188-9.
PMID: 28974247DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Ying Li, PhD
Chengdu University of Traditional Chinese Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 22, 2017
First Posted
April 28, 2017
Study Start
June 1, 2016
Primary Completion
June 1, 2019
Study Completion
September 10, 2019
Last Updated
September 19, 2019
Record last verified: 2019-09
Data Sharing
- IPD Sharing
- Will not share